HOME >> MEDICINE >> NEWS
Hormone therapy offers new hope for ovarian cancer patients

Researchers at the University of Edinburgh have shown that hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.

The study, published today in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Letrozole hormone therapy already used with great success in the treatment of breast tumours - attacks cancer by turning off its oestrogen supply. But scientists now believe that in those ovarian cancers which are highly sensitive to oestrogen, this blocking mechanism could slow the growth and spread of disease.

The study was funded by Cancer Research UK and involved 44 women with high oestrogen receptor (ER) levels, whose cancer had relapsed after surgery and chemotherapy.

Scientists used a blood-borne tumour marker, CA-125, to track the progress of tumours during hormone treatment. They discovered that one quarter of the women showed no tumour growth after six months of anti-oestrogen therapy, and 33 per cent of the group with the greatest ER values showed a positive response which delayed the use of chemotherapy.

John F. Smyth, Professor of Medical Oncology at the University of Edinburgh, led the research programme.

He said: This is an important landmark in the research and treatment of ovarian cancer. Despite intense scientific research over the past 20 years, there have been few new leads in our understanding of how this disease operates. But this study suggests that the addition of hormone therapy to our treatment strategy could extend and improve the lives of women with cancer.

Ovarian cancer is the most commonly fatal of gynaecological cancers, affecting 1 in 48 women. Nearly 7,000 new cases are diagnosed in the UK each year.

Current treatment involves surgery and chemoth
'"/>

Contact: Anna Smyth
anna.smyth@ed.ac.uk
44-131-651-4400
University of Edinburgh
14-Jun-2007


Page: 1 2

Related medicine news :

1. Hormone regulates fondness for food
2. Hormone drug type makes survival difference in advanced breast cancer
3. Hormone replacement therapy may improve trip down memory lane
4. Hormone-replacement therapy hurts hearing, study finds
5. Hormones could be prescription for living longer
6. Hormone found to decrease appetite and increase activity
7. Hormone therapy may prevent heart attacks for women in their 50s
8. Hormone use linked to increased breast cancer risk among black women
9. Hormone can predict pulmonary hypertension and potential death or survival
10. Hormone linked to good hearing as we age
11. Hormone aldosterone is promising target for stroke treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/1/2020)... ... 01, 2020 , ... Velocidy Bio ’s Dutch biotech partner, Molecular Biology ... decreases the testing time for SARS-CoV-2 to eight minutes, compared to current systems that ... shoebox could perform a hundred and eighty (180) amplification runs a day, an almost ...
(Date:3/30/2020)... DOWNERS GROVE, Ill. (PRWEB) , ... March 30, ... ... to its name as the coronavirus pandemic sweeps the country. In an effort ... the company’s software solutions are enabling police interaction with community members while minimizing ...
(Date:3/28/2020)... ... March 27, 2020 , ... ... is now offering telemedicine as an alternative approach to seeing their patients. ... doctors in the comfort of their own home or office using video conference ...
(Date:3/27/2020)... ... March 27, 2020 , ... Justin P. ... Top Docs. Dr. Kubeck has been approved every year consecutively since 2016. Dr. ... in Spinal Surgery. , Dr. Kubeck’s medical education began at Thomas Jefferson ...
(Date:3/22/2020)... ... March 21, 2020 , ... ... the Modular Home Builders Association (MHBA), have been working with state and federal ... has been advocating for greater use of modular construction to address the nation’s ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... ... April 02, 2020 , ... NCPDP has elected its ... Meeting of the NCPDP Board of Trustees on Wednesday, May 6, 2020. , ... M.B.A., PBM Practice Lead, Point-of-Care Partners, newly elected to the Board of Trustees. , ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... is continuing her partnership with the esteemed Haute Beauty network. , The Haute ... present Dr. Green as a leading Anti-Aging Expert. , Haute Beauty offers a ...
(Date:3/30/2020)... ... 30, 2020 , ... Energage, the leader in helping organizations ... series of survey question packs that enable organizations to keep the lines of ... the current situation continues to evolve, The Energage Operational Readiness Survey Packs offer ...
Breaking Medicine Technology:
Cached News: